A retrospective cohort study suggested that people with color blindness may have a higher risk of mortality from bladder ...

ImmunityBio’s IBRX QUILT-2.005 trial tops enrollment forecasts; BLA filing targeted by year-end after positive ANKTIVA+BCG ...

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his abdomen after drinking water. It was just a fleeting moment; one he brushed ...

A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

When you learn you have bladder cancer, it’s only natural to ask: "Can I survive this, for how long, and can I expect to be cured?" You may have searched online for survival rate information. These ...

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.

A mum-of-two from Kirkby Lonsdale has become the first patient in the region to receive innovative treatment for bladder ...

The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.